CNS angiocentric stromal tumor (CAST), PDGFRA-mutant, a novel entity histologically mimicking meningioangiomatosis and radiologically correlating with giant Virchow-Robin spaces. Read more about CNS angiocentric stromal tumor (CAST), PDGFRA-mutant, a novel entity histologically mimicking meningioangiomatosis and radiologically correlating with giant Virchow-Robin spaces.
Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patients. Read more about Diffuse astrocytoma, AYA-type, frequently MAPK-altered: report of 45 patients.
The RNA-binding protein IGF2BP1 regulates stability of mRNA transcribed from FOXM1 target genes in hypermitotic meningiomas. Read more about The RNA-binding protein IGF2BP1 regulates stability of mRNA transcribed from FOXM1 target genes in hypermitotic meningiomas.
Gene transcript fusions are associated with clinical outcomes and molecular groups of meningiomas. Read more about Gene transcript fusions are associated with clinical outcomes and molecular groups of meningiomas.
Canine meningiomas are comprised of 3 DNA methylation groups that resemble the molecular characteristics of human meningiomas. Read more about Canine meningiomas are comprised of 3 DNA methylation groups that resemble the molecular characteristics of human meningiomas.
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade. Read more about "De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockade.
Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis. Read more about Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis.
Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas. Read more about Correction: Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.
Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas. Read more about Increased mRNA expression of CDKN2A is a transcriptomic marker of clinically aggressive meningiomas.
Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification. Read more about Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
